Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.

Sharif R, Fritzler MJ, Mayes MD, Gonzalez EB, McNearney TA, Draeger H, Baron M; Canadian Scleroderma Research Group, Furst DE, Khanna DK, del Junco DJ, Molitor JA, Schiopu E, Phillips K, Seibold JR, Silver RM, Simms RW; GENISOS Study Group, Perry M, Rojo C, Charles J, Zhou X, Agarwal SK, Reveille JD, Assassi S, Arnett FC.

J Rheumatol. 2011 Aug;38(8):1622-30. doi: 10.3899/jrheum.110071. Epub 2011 May 15.

2.

Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.

Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J, Fritzler MJ, Ahn C, Arnett FC; GENISOS Study Group.

Semin Arthritis Rheum. 2001 Apr;30(5):332-46.

PMID:
11303306
3.

The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.

Tall F, Dechomet M, Riviere S, Cottin V, Ballot E, Tiev KP, Montin R, Morin C, Chantran Y, Grange C, Jullien D, Ninet J, Chretien P, Cabane J, Fabien N, Johanet C.

Scand J Immunol. 2017 Jan;85(1):73-79. doi: 10.1111/sji.12510.

PMID:
27864990
4.

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, Tan FK, McNearney T, Fischbach M, Fritzler MJ, Mayes MD, Reveille JD.

Ann Rheum Dis. 2010 May;69(5):822-7. doi: 10.1136/ard.2009.111906. Epub 2009 Jul 12. Erratum in: Ann Rheum Dis. 2011 May;70(5):880.

5.

A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr.

Arthritis Rheum. 2012 Sep;64(9):2986-94. doi: 10.1002/art.34482.

6.

Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.

Peterson LK, Jaskowski TD, Mayes MD, Tebo AE.

Immunol Res. 2016 Apr;64(2):483-8. doi: 10.1007/s12026-015-8710-9.

PMID:
26467972
7.

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.

Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM.

Arthritis Rheum. 1999 Mar;42(3):465-74.

8.

Anti-U3 RNP autoantibodies in systemic sclerosis.

Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr.

Arthritis Rheum. 2009 Apr;60(4):1112-8. doi: 10.1002/art.24409.

9.

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis.

Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, Leroy EC, Fritzler MJ.

Arthritis Rheum. 1996 Jul;39(7):1151-60.

PMID:
8670324
10.

Association of HLA class II genes with systemic sclerosis in Koreans.

Kang SH, Park MH, Song EY, Kang SJ, Lee EB, Song YW, Takeuchi F.

J Rheumatol. 2001 Jul;28(7):1577-83.

PMID:
11469465
11.

HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients.

Fanning GC, Welsh KI, Bunn C, Du Bois R, Black CM.

Br J Rheumatol. 1998 Feb;37(2):201-7.

PMID:
9569077
12.

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE; Juvenile Dermatomyositis Research Group (JDRG).

Rheumatology (Oxford). 2007 Dec;46(12):1786-91. Epub 2007 Nov 14.

PMID:
18003662
13.

Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.

Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K, Ogasawara T, Hirakata M, Ohosone Y, Kaburaki J, Okano Y, Mimori T.

Intern Med. 1999 Apr;38(4):336-44.

14.

Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.

Rodriguez-Reyna TS, Hinojosa-Azaola A, Martinez-Reyes C, Nuñez-Alvarez CA, Torrico-Lavayen R, García-Hernández JL, Cabiedes-Contreras J.

Autoimmunity. 2011 Nov;44(7):576-84. doi: 10.3109/08916934.2011.592886. Epub 2011 Aug 30.

PMID:
21875377
15.

Clinical, immunologic, and genetic features of familial systemic sclerosis.

Assassi S, Arnett FC, Reveille JD, Gourh P, Mayes MD.

Arthritis Rheum. 2007 Jun;56(6):2031-7.

16.

Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).

Falkner D, Wilson J, Fertig N, Clawson K, Medsger TA Jr, Morel PA.

J Rheumatol. 2000 May;27(5):1196-202.

PMID:
10813287
17.

HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.

Rodriguez-Reyna TS, Mercado-Velázquez P, Yu N, Alosco S, Ohashi M, Lebedeva T, Cruz-Lagunas A, Núñez-Álvarez C, Cabiedes-Contreras J, Vargas-Alarcón G, Granados J, Zúñiga J, Yunis E.

PLoS One. 2015 May 20;10(5):e0126727. doi: 10.1371/journal.pone.0126727. eCollection 2015.

18.

Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.

Vigone B, Santaniello A, Marchini M, Montanelli G, Caronni M, Severino A, Beretta L.

Rheumatology (Oxford). 2015 Apr;54(4):707-11. doi: 10.1093/rheumatology/keu381. Epub 2014 Sep 16.

PMID:
25231181
19.

Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.

Tan FK, Arnett FC, Reveille JD, Ahn C, Antohi S, Sasaki T, Nishioka K, Bona CA.

Arthritis Rheum. 2000 Nov;43(11):2464-71.

20.

Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis.

Hasegawa M, Hatta Y, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K.

Mod Rheumatol. 2013 Sep;23(5):913-9. doi: 10.1007/s10165-012-0764-0. Epub 2012 Sep 19.

PMID:
22990335

Supplemental Content

Support Center